首页> 美国卫生研究院文献>Cancer Cell International >Combination of the natural product capsaicin and docetaxel synergistically kills human prostate cancer cells through the metabolic regulator AMP-activated kinase
【2h】

Combination of the natural product capsaicin and docetaxel synergistically kills human prostate cancer cells through the metabolic regulator AMP-activated kinase

机译:天然产物辣椒素和多西他赛的组合通过代谢调节剂AMP激活的激酶协同杀死人类前列腺癌细胞。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundCurrent chemotherapy for castration-resistant prostate cancer is established on taxane-based compounds like docetaxel. However, eventually, the development of toxic side effects and resistance limits the therapeutic benefit being the major concern in the treatment of prostate cancer. Combination therapies in many cases, enhance drug efficacy and delay the appearance of undesired effects, representing an important option for the treatment of castration-resistant prostate cancer. In this study, we tested the efficacy of the combination of docetaxel and capsaicin, the pungent ingredient of hot chili peppers, on prostate cancer cells proliferation.
机译:背景技术当前的针对去势抵抗性前列腺癌的化学疗法建立在紫杉烷类化合物如多西紫杉醇上。然而,最终,毒性副作用和抗药性的发展限制了治疗益处,这是前列腺癌治疗中的主要关注点。在许多情况下,联合疗法可增强药物疗效并延缓不良作用的出现,这代表了去势抵抗性前列腺癌的重要治疗选择。在这项研究中,我们测试了多西他赛和辣椒素(辣椒的辛辣成分)的组合对前列腺癌细胞增殖的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号